An Open Label, Single-Center, Single Dose Combination of HSK3486 and Etomidate Intravenous Bolus Injection to Determine the Safety, Pharmacodynamics and Pharmacokinetics for Induction of Anesthesia in Healthy Male Subjects

Trial Profile

An Open Label, Single-Center, Single Dose Combination of HSK3486 and Etomidate Intravenous Bolus Injection to Determine the Safety, Pharmacodynamics and Pharmacokinetics for Induction of Anesthesia in Healthy Male Subjects

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Nov 2016

At a glance

  • Drugs Etomidate (Primary) ; HSK 3486 (Primary)
  • Indications Anaesthesia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Acronyms HSK3486 SAD_04
  • Sponsors Sichuan Haisco Pharmaceutical
  • Most Recent Events

    • 25 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top